SARS News and Research

RSS

Scientists develop a smartwatch-based device for early detection of COVID-19

Scientists have developed a wearable device that can detect the early onset of COVID-19 in real-time by analyzing the aberrant changes in physiological parameters caused by SARS-CoV-2 infection.

30 Nov 2021

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

A new paper deals with the identification of an antiviral compound that could help in developing additional drugs to help fight COVID-19.

30 Nov 2021

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Research suggests that COVID-19 from Delta or Alpha infections is clinically similar, yet Delta is more transmissible than Alpha.

30 Nov 2021

Predicting the far-field transmission of SARS-CoV-2 indoors

Researchers from the UK predicted the infection rate by the far-field airborne transmission of SARS-CoV-2 indoors.

30 Nov 2021

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.

30 Nov 2021

Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Pregnant patients with mild to moderate COVID-19 were treated with MAb and reported no adverse effects.

30 Nov 2021

Increased illness burden of COVID-19 among unvaccinated first responders

A new study gathered data from the HEROES-RECOVER prospective cohorts and reported an increased illness burden of COVID-19 among unvaccinated first responders.

30 Nov 2021

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

In a recent study, published on the bioRxiv* preprint server, researchers identified human LRRC15 as an inhibitory receptor for SARS-CoV-2 entry, which directly binds to the receptor-binding domain (RBD) of the spike protein with a moderate affinity and inhibits spike-mediated entry.

29 Nov 2021

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

In a new study published on the bioRxiv* preprint server, scientists investigated several virological features of the Delta spike protein.

29 Nov 2021

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

In a new study, published on the bioRxiv* preprint server, scientists aimed to determine the reaction of the molnupiravir parent drug (NHC) to different SARS-CoV-2 Variants of Concern (VoCs). They also sought to establish the therapeutic window in a human lung cell model.

29 Nov 2021

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.

29 Nov 2021

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

Saliva samples are easy to obtain and useful for measuring antibodies to SARS-CoV-2 in children, which could facilitate epidemiological surveillance in school settings.

29 Nov 2021

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Researchers attempt to predict future transmission rates by identifying multiple scenarios that could occur over the next year.

29 Nov 2021

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

Researchers study human single nucleotide variants (SNVs) using machine learning to identify amino acid changes that alter kinase-bound sequence motifs.

29 Nov 2021

An update of what is currently known about Omicron

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE).

29 Nov 2021

SARS-CoV-2 can directly invade human kidney cells, research shows

Up to 25% of patients' COVID-19 cases involve acute kidney injury—the kidneys' equivalent of a heart attack.

29 Nov 2021

Glycosylation and disulfide bonding profile of SARS-CoV-2 spike glycoprotein

Researchers found that virus-like particles produced by co-expression of SARS-CoV-2 S, membrane, envelope, and nucleocapsid proteins contain S glycoproteins, which are modified by complex carbohydrates.

29 Nov 2021

Extended host range for SARS-CoV-2 variants of concern

Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.

29 Nov 2021

Does vaccine or infection induced immunity better protect against SARS-CoV-2 variants?

A study investigated whether vaccine- or infection-induced immunity is relatively less effective against infection by specific VOCs.

29 Nov 2021

Study finds atazanavir inhibits main SARS-CoV-2 protease

Research shows that ATV has different antiviral activity compared to PAXLOVID™, encouraging further research.

29 Nov 2021

SARS News and Research

Scientists develop a smartwatch-based device for early detection of COVID-19

Structure-guided virtual screening identifies novel SARS-CoV-2 Mpro inhibitors

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Predicting the far-field transmission of SARS-CoV-2 indoors

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Increased illness burden of COVID-19 among unvaccinated first responders

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Genetic variations affect and rewire phosphorylation signaling networks in SARS-CoV-2 infection

An update of what is currently known about Omicron

SARS-CoV-2 can directly invade human kidney cells, research shows

Glycosylation and disulfide bonding profile of SARS-CoV-2 spike glycoprotein

Extended host range for SARS-CoV-2 variants of concern

Does vaccine or infection induced immunity better protect against SARS-CoV-2 variants?

Study finds atazanavir inhibits main SARS-CoV-2 protease

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News